麻豆传媒

Questionable efficacy, potential toxicity "tips the scales" against clofazimine-based regimen

Virologic suppression rate was 94.2% in both groups

Three-drug combo over 4 months was comparable to standard treatment over 6 months

Trial halted early for efficacy despite not meeting significance criteria on primary endpoint

Weekly injections reduced liver fat by 31% at 6 months

Lowering blood pressure, cholesterol prove feasible in randomized trials

Fixed-dose combination shows promise in small trial

Unsanitary conditions resulted in infections in three people; investigation still ongoing

Levels of IL-6, high-sensitivity CRP, and soluble CD163 were decreased with the GLP-1 agonist

Other data showed high uptake of doxycycline post-exposure prophylaxis among PrEP users

Trial is "essential first step" in exploring this public health strategy, researcher says

Main focus now will be approaches using broadly neutralizing HIV-1 antibodies, researchers say

Antiviral should have been recommended sooner for non-ventilated patients, editorialist argues

Trial shows noninferiority to daily antiretroviral pills for controlling HIV